Company Information

HESTER BIOSCIENCES LTD.

NSE : HESTERBIOBSE : 524669ISIN CODE : INE782E01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE1653.25-27.5 (-1.64 %)
PREV CLOSE ( ) 1680.75
OPEN PRICE ( ) 1669.45
BID PRICE (QTY) 1651.30 (4)
OFFER PRICE (QTY) 1655.95 (4)
VOLUME 362
TODAY'S LOW / HIGH ( )1651.00 1680.00
52 WK LOW / HIGH ( )1292.9 1928.45
NSE1650.15-34.35 (-2.04 %)
PREV CLOSE( ) 1684.50
OPEN PRICE ( ) 1659.25
BID PRICE (QTY) 1651.20 (1)
OFFER PRICE (QTY) 1654.25 (1)
VOLUME 5396
TODAY'S LOW / HIGH( ) 1649.00 1680.65
52 WK LOW / HIGH ( )1292.85 1939.95
ChairmanBhupendra V Gandhi
Managing DirectorRajiv Gandhi
Company SecretaryVinod Mali
Executive DirectorPriya Gandhi
Alternate DirectorNina Gandhi
Promoter & Non-Executive DirectorSanjiv Gandhi
Ravin Gandhi
Non Executive Independent DirectorSandhya Patel
Ashok Bhadakal
Ameet Desai
Anil Jain
Jatin Trivedi
Incorporation Year : 1987

Registered Office :

Address : Pushpak’ 1st Floor,Panchvati Circle,Motila Hirabhai Road Ahmedabad,
Gujarat-380006 .

Phone : 079 – 26445106

Email :  mail@hester.in 

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.